CANCIDAS 70 MG
CASPOFUNGIN (CASPOFUNGIN ACETATE) : 70 MG · DIN 02244266 · MERCK CANADA INC
Health Canada status: MARKETED
What is CANCIDAS?
CANCIDAS 70 MG contains CASPOFUNGIN (CASPOFUNGIN ACETATE) : 70 MG. It is listed in the Health Canada Drug Product Database under DIN 02244266, held by MERCK CANADA INC, supplied as POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 05-Jul-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02244266 |
|---|---|
| Brand name | CANCIDAS |
| Generic / active ingredient | CASPOFUNGIN (CASPOFUNGIN ACETATE) : 70 MG |
| Manufacturer | MERCK CANADA INC |
| Strength | 70 MG |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | J02AX04 CASPOFUNGIN |
| AHFS class | 08:14.16 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 05-Jul-2006 |
| Original market date | 2001-10-23 00:00:00 |
Is CASPOFUNGIN in shortage in Canada?
A Canadian shortage report is on file for this molecule: Discontinued — reported by FRESENIUS KABI CANADA LTD, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code J02AX04 CASPOFUNGIN. 5 of 12 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CASPOFUNGIN FOR INJECTION | 50 MG | POWDER FOR SOLUTION | JUNO PHARMACEUTICALS CORP. | MARKETED | DIN 02460947 |
| CASPOFUNGIN FOR INJECTION | 50 MG | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02486989 |
| CASPOFUNGIN FOR INJECTION | 70 MG | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02486997 |
| CASPOFUNGIN FOR INJECTION | 70 MG | POWDER FOR SOLUTION | JUNO PHARMACEUTICALS CORP. | MARKETED | DIN 02460955 |
| CANCIDAS | 50 MG | POWDER FOR SOLUTION | MERCK CANADA INC | CANCELLED POST MARKET | DIN 02244265 |
| CASPOFUNGIN ACETATE FOR INJECTION | 50 MG | POWDER FOR SOLUTION | STERIMAX INC | APPROVED | DIN 02456133 |
| CASPOFUNGIN ACETATE FOR INJECTION | 50 MG | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | DIN 02389193 |
| CASPOFUNGIN ACETATE FOR INJECTION | 70 MG | POWDER FOR SOLUTION | STERIMAX INC | APPROVED | DIN 02456125 |
| CASPOFUNGIN ACETATE FOR INJECTION | 70 MG | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | DIN 02389207 |
| CASPOFUNGIN POWDER FOR INJECTION | 50 MG | POWDER FOR SOLUTION | TEVA CANADA LIMITED | CANCELLED PRE MARKET | DIN 02448815 |
Who else supplies CASPOFUNGIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CASPOFUNGIN appears in 82 registered pack listings across 6 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.